Boom-IBD Clinical Trial

Completed · Not applicable

Conditions studied: IBD

In brief

Feasibility study of neuromodulation in patients with IBD.

Key facts

Study ID

NCT05414955

Run by

Boomerang Medical

People needed

40

Starts

2022-10-01

Expected to finish

2024-12-06

Last updated by the study team

2025-06-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Phillip Fleshner, Inc. — Los Angeles, California, United States
• Palo Alto Medical Foundation Research Institute — Palo Alto, California, United States
• CU Anschutz — Aurora, Colorado, United States
• Kansas Gastroenterology — Wichita, Kansas, United States
• Las Vegas Medical Research — Las Vegas, Nevada, United States
• The Mount Sinai Medical Center — New York, New York, United States
• Columbia University Irving Medical Center — New York, New York, United States
• University of Pennsylvania, Perelman School of Medicine Division of Colorectal Surgery — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.